HY-004 provides a new treatment alternative for use in patients on anti-coagulant therapies undergoing dental procedures that have a risk of bleeding or complication HY-004 administered locally had ...

Please provide your email address to receive an email when new articles are posted on . Tranexamic acid utilization did not increase the risk for thrombotic events in high-risk patients. Tranexamic ...

Prophylactic use of tranexamic acid at the time of cesarean delivery has been shown to decrease the calculated blood loss, but the effect on the need for blood transfusions is unclear. We randomly ...

Perioperative bleeding is common in patients undergoing noncardiac surgery. Tranexamic acid is an antifibrinolytic drug that may safely decrease such bleeding. We conducted a trial involving patients ...

Fatal mix-ups between tranexamic acid and spinal anesthetics have prompted a strong safety warning by the European Medicines Agency (EMA), urging healthcare professionals to ensure the drug is ...

Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically rather than intravenously did not meet its primary endpoint of reducing seizures and was stopped ...